Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Sensitivity analysis of randomized clinical trials assessing the predictive value of cisplatin-based neoadjuvant chemotherapy for overall survival.
| RR for Fixed Effect | [95%CI] | |
|---|---|---|
| Overall analysis | 0.97 | [0.90–1.05] |
| Dose-intense cisplatin ≥ 72.5 mg/m2/3 weeks | 0.87 | [0.76–0.98] |
| Dose-intense cisplatin ≥ 105 mg/m2/3 weeks | 0.79 | [0.67–0.93] |
| Triplet cisplatin-based chemotherapy (yes) | 0.97 | [0.83–1.13] |
| Chemotherapy duration (≤6 weeks) | 0.91 | [0.80; 1.04] |
RR, relative risk; CI, confidence interval.
